Preparation and evaluation of oral solid heparin using emulsifier and adsorbent for in vitro and in vivo studies

International Journal of Pharmaceutics
Yukako ItoKanji Takada

Abstract

Oral anticoagulant therapy with heparin has been challenged by formulating heparin in oral solid preparation. As heparin, low molecular weight heparin (LMWH) was used. LMWH was dispersed with a surfactant used for the self-microemulsifying drug delivery system (SMEDDS), PEG-8 caprylic/capric glycerides (Labrasol), and the mixture was solidified with three kinds of adsorbents, microporous calcium silicate (Florite RE), magnesium alminometa silicate (Neusilin US(2)) and silicon dioxide (Sylysia 320). The in vitro release study showed that the T50%s were 3.2+/-0.1min for Sylysia 320, 4.6+/-0.2min for Florite RE, 13.7+/-0.1min for Neusilin US(2). The in vivo rat absorption study showed that Florite RE system had the highest C(max), 0.42+/-0.01IU/mL and AUC, 0.59+/-0.06IUh/mL, where plasma LMWH levels were measured as anti-Xa activity. Other preparations had the C(max) and AUC, 0.12+/-0.01IU/mL and 0.15+/-0.02IUh/mL for Neusilin US(2) and 0.25+/-0.02IU/mL and 0.40+/-0.03IUh/mL for Sylysia 320, respectively. The bioavailability (BA) of LMWH from the microporous calcium silicate preparation, Florite RE, was 18.8% in rats by comparing the AUC obtained after i.v. injection of LMWH, 40IU/kg to another group of rats. Florite RE system was...Continue Reading

Citations

Apr 9, 2010·Indian Journal of Pharmaceutical Sciences·G Ahuja, K Pathak
Apr 12, 2011·Drug Development and Industrial Pharmacy·Myung Joo KangSang-Cheol Chi
Jul 16, 2015·Drug Development and Industrial Pharmacy·Boyu JingZhonggui He
Oct 4, 2011·Drug Development and Industrial Pharmacy·C M HentzschelC S Leopold
Jan 29, 2013·Journal of Drug Targeting·Canan IskenderoğluYeşim Bardakçi
Jun 2, 2007·Journal of Drug Targeting·Yukako ItoKanji Takada
Feb 11, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·A Malzert-FréonS Rault
Jun 10, 2009·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Subhashis ChakrabortySanjay Singh
May 28, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·L JavotP Maincent
Feb 3, 2011·Medicinal Research Reviews·Rishi PaliwalSuresh P Vyas
Jul 8, 2015·Therapeutic Delivery·Bettina Ralay-RanaivoRuxandra Gref
Jun 21, 2016·Advanced Drug Delivery Reviews·Sam MaherDavid J Brayden
Jul 2, 2016·Pharmaceuticals·Ana Rita NevesMadalena Pinto
Apr 19, 2017·Materials Science & Engineering. C, Materials for Biological Applications·A TamayoJ Rubio
Mar 31, 2010·Molecular Pharmaceutics·Jin Woo ParkYoungro Byun
Jan 19, 2007·Advances in Colloid and Interface Science·Aviram Spernath, Abraham Aserin

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.